Unraveling the Transcriptional Regulatory Machinery in Chondrogenesis

Overview

Journal J Bone Miner Metab

Specialty Endocrinology

Date 2011 May 20

PMID 21594584

Citations 85

Authors

Haruhiko Akiyama

Veronique Lefebvre

Affiliations

Soon will be listed here.

Abstract

Since the discovery of SOX9 mutations in the severe human skeletal malformation syndrome campomelic dysplasia in 1994, Sox9 was shown to be both required and sufficient for chondrocyte specification and differentiation. At the same time, its distant relatives Sox5 and Sox6 were shown to act in redundancy with each other to robustly enhance its functions. The Sox trio is currently best known for its ability to activate the genes for cartilage-specific extracellular matrix components. Sox9 and Sox5/6 homodimerize through domains adjacent to their Sry-related high-mobility-group DNA-binding domain to increase the efficiency of their cooperative binding to chondrocyte-specific enhancers. Sox9 possesses a potent transactivation domain and thereby recruits diverse transcriptional co-activators, histone-modifying enzymes, subunits of the mediator complex, and components of the general transcriptional machinery, such as CBP/p300, Med12, Med25, and Wwp2. This information helps us begin to unravel the mechanisms responsible for Sox9-mediated transcription. We review here the discovery of this master chondrogenic trio and its roles in chondrogenesis in vivo and at the molecular level, and we discuss how these pioneering studies open the way for many additional studies that are needed to further increase our understanding of the transcriptional regulatory machinery operating in chondrogenesis.

Citing Articles

SOX-5 Transcription Factor: a Novel Psoriatic Autoantigen Preferentially Found in Women.

Orbai A, Fiorentino D, Perin J, Darrah E, Yang Q, Gutierrez-Alamillo L ACR Open Rheumatol. 2024; 6(12):807-819.

PMID: 39218617 PMC: 11638130. DOI: 10.1002/acr2.11740.

Molecular Developmental Biology of Fibrodysplasia Ossificans Progressiva: Measuring the Giant by Its Toe.

Towler O, Shore E, Kaplan F Biomolecules. 2024; 14(8).

PMID: 39199396 PMC: 11353020. DOI: 10.3390/biom14081009.

Regenerative capacity of human pluripotent stem cell-derived articular chondrocytes in vitro.

Raftery R, Pregizer S, Kocher S, Craft A J Orthop Res. 2024; 42(8):1841-1851.

PMID: 38433390 PMC: 11222035. DOI: 10.1002/jor.25823.

Chondrocyte Homeostasis and Differentiation: Transcriptional Control and Signaling in Healthy and Osteoarthritic Conditions.

Michelacci Y, Baccarin R, Rodrigues N Life (Basel). 2023; 13(7).

PMID: 37511835 PMC: 10381434. DOI: 10.3390/life13071460.

Fabrication of a Smart Fibrous Biomaterial That Harbors an Active TGF-β1 Peptide: A Promising Approach for Cartilage Regeneration.

Mantsou A, Papachristou E, Keramidas P, Lamprou P, Pitou M, Papi R Biomedicines. 2023; 11(7).

PMID: 37509529 PMC: 10377373. DOI: 10.3390/biomedicines11071890.

References

Lee H, Park U, Kim E, Um S . MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. EMBO J. 2007; 26(15):3545-57. PMC: 1949011. DOI: 10.1038/sj.emboj.7601797. View

Han Y, Lefebvre V . L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol. 2008; 28(16):4999-5013. PMC: 2519711. DOI: 10.1128/MCB.00695-08. View

Huang W, Zhou X, Lefebvre V, de Crombrugghe B . Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer. Mol Cell Biol. 2000; 20(11):4149-58. PMC: 85784. DOI: 10.1128/MCB.20.11.4149-4158.2000. View

Bridgewater L, Walker M, Miller G, Ellison T, Holsinger L, Potter J . Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements. Nucleic Acids Res. 2003; 31(5):1541-53. PMC: 149823. DOI: 10.1093/nar/gkg230. View

Akiyama H, Chaboissier M, Martin J, Schedl A, de Crombrugghe B . The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002; 16(21):2813-28. PMC: 187468. DOI: 10.1101/gad.1017802. View

Kawakami Y, Tsuda M, Takahashi S, Taniguchi N, Esteban C, Zemmyo M . Transcriptional coactivator PGC-1alpha regulates chondrogenesis via association with Sox9. Proc Natl Acad Sci U S A. 2005; 102(7):2414-9. PMC: 548985. DOI: 10.1073/pnas.0407510102. View

Topol L, Chen W, Song H, Day T, Yang Y . Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J Biol Chem. 2008; 284(5):3323-3333. PMC: 2631972. DOI: 10.1074/jbc.M808048200. View

Savagner P, Krebsbach P, Hatano O, Miyashita T, Liebman J, Yamada Y . Collagen II promoter and enhancer interact synergistically through Sp1 and distinct nuclear factors. DNA Cell Biol. 1995; 14(6):501-10. DOI: 10.1089/dna.1995.14.501. View

Lefebvre V, Garofalo S, Zhou G, Metsaranta M, Vuorio E, de Crombrugghe B . Characterization of primary cultures of chondrocytes from type II collagen/beta-galactosidase transgenic mice. Matrix Biol. 1994; 14(4):329-35. DOI: 10.1016/0945-053x(94)90199-6. View

10.

Bridgewater L, Lefebvre V, de Crombrugghe B . Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem. 1998; 273(24):14998-5006. DOI: 10.1074/jbc.273.24.14998. View

11.

Furumatsu T, Tsuda M, Yoshida K, Taniguchi N, Ito T, Hashimoto M . Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem. 2005; 280(42):35203-8. DOI: 10.1074/jbc.M502409200. View

12.

Bernard P, Tang P, Liu S, Dewing P, Harley V, Vilain E . Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum Mol Genet. 2003; 12(14):1755-65. DOI: 10.1093/hmg/ddg182. View

13.

Xie W, Zhang X, Sakano S, Lefebvre V, Sandell L . Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res. 1999; 14(5):757-63. DOI: 10.1359/jbmr.1999.14.5.757. View

14.

Nagy A, Kenesi E, Rentsendorj O, Molnar A, Szenasi T, Sinko I . Evolutionarily conserved, growth plate zone-specific regulation of the matrilin-1 promoter: L-Sox5/Sox6 and Nfi factors bound near TATA finely tune activation by Sox9. Mol Cell Biol. 2010; 31(4):686-99. PMC: 3028657. DOI: 10.1128/MCB.00019-10. View

15.

Zhou R, Bonneaud N, Yuan C, de Santa Barbara P, Boizet B, Schomber T . SOX9 interacts with a component of the human thyroid hormone receptor-associated protein complex. Nucleic Acids Res. 2002; 30(14):3245-52. PMC: 135763. DOI: 10.1093/nar/gkf443. View

16.

Smits P, Li P, Mandel J, Zhang Z, Deng J, Behringer R . The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell. 2001; 1(2):277-90. DOI: 10.1016/s1534-5807(01)00003-x. View

17.

Otto F, Thornell A, Crompton T, Denzel A, Gilmour K, Rosewell I . Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997; 89(5):765-71. DOI: 10.1016/s0092-8674(00)80259-7. View

18.

Akiyama H, Stadler H, Martin J, Ishii T, Beachy P, Nakamura T . Misexpression of Sox9 in mouse limb bud mesenchyme induces polydactyly and rescues hypodactyly mice. Matrix Biol. 2007; 26(4):224-33. DOI: 10.1016/j.matbio.2006.12.002. View

19.

Huang W, Lu N, Eberspaecher H, de Crombrugghe B . A new long form of c-Maf cooperates with Sox9 to activate the type II collagen gene. J Biol Chem. 2002; 277(52):50668-75. DOI: 10.1074/jbc.M206544200. View

20.

Amano K, Hata K, Muramatsu S, Wakabayashi M, Takigawa Y, Ono K . Arid5a cooperates with Sox9 to stimulate chondrocyte-specific transcription. Mol Biol Cell. 2011; 22(8):1300-11. PMC: 3078073. DOI: 10.1091/mbc.E10-07-0566. View